Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice (Q38023254)

27 August 2017

title

Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice (English)

1 reference

27 August 2017

1 reference

Rochelle F Rubin

1

1 reference

27 August 2017

Huda-Marie Kuttab

series ordinal

2

1 reference

27 August 2017

Rami S Rihani

series ordinal

3

1 reference

27 August 2017

Thomas J Reutzel

series ordinal

4

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Journal of Community Health

27 August 2017

published in

1 reference

27 August 2017

volume

37

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

1145-1150

1 reference

https://scigraph.springernature.com/pub.10.1007/s10900-012-9581-9

27 August 2017

exact match

0 references

cites work

The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Human papillomavirus vaccination series initiation and completion, 2008-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Factors associated with completion of the human papillomavirus vaccine series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Human papillomavirus genotype distribution in Madrid and correlation with cytological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10900-012-9581-9

Human papillomavirus molecular testing in women with low grade cervical lesions: experience from an Italian hospital.

21 January 2018

1 reference

12 December 2020

Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen

1 reference

12 December 2020

General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

1 reference

12 December 2020

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

10.1007/S10900-012-9581-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1031368217

0 references

1 reference